Literature DB >> 22652026

Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study.

James W Dodd1, Ai Wern Chung, Martin D van den Broek, Thomas R Barrick, Rebecca A Charlton, Paul W Jones.   

Abstract

RATIONALE: Brain pathology is a poorly understood systemic manifestation of chronic obstructive pulmonary disease (COPD). Imaging techniques using magnetic resonance (MR) diffusion tensor imaging (DTI) and resting state functional MR imaging (rfMRI) provide measures of white matter microstructure and gray functional activation, respectively.
OBJECTIVES: We hypothesized that patients with COPD would have reduced white matter integrity and that functional communication between gray matter resting-state networks would be significantly different to control subjects. In addition, we tested whether observed differences related to disease severity, cerebrovascular comorbidity, and cognitive dysfunction.
METHODS: DTI and rfMRI were acquired in stable nonhypoxemic patients with COPD (n = 25) and compared with age-matched control subjects (n = 25). Demographic, disease severity, stroke risk, and neuropsychologic assessments were made.
MEASUREMENTS AND MAIN RESULTS: Patients with COPD (mean age, 68; FEV(1) 53 ± 21% predicted) had widespread reduction in white matter integrity (46% of white matter tracts; P < 0.01). Six of the seven resting-state networks showed increased functional gray matter activation in COPD (P < 0.01). Differences in DTI, but not rfMRI, remained significant after controlling for stroke risk and smoking (P < 0.05). White matter integrity and gray matter activation seemed to account for difference in cognitive performance between patients with COPD and control subjects.
CONCLUSIONS: In stable nonhypoxemic COPD there is reduced white matter integrity throughout the brain and widespread disturbance in functional activation of gray matter, which may contribute to cognitive dysfunction. White matter microstructural integrity but not gray matter functional activation is independent of smoking and cerebrovascular comorbidity. The mechanisms remain unclear, but may include cerebral small vessel disease caused by COPD.

Entities:  

Mesh:

Year:  2012        PMID: 22652026     DOI: 10.1164/rccm.201202-0355OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  44 in total

1.  Reduced axial diffusivity and increased mode and T2 signals in cerebral white matter of chronic obstructive pulmonary disease using tract-based spatial statistics.

Authors:  Sekwang Lee; Sung-Bom Pyun; Woo-Suk Tae
Journal:  Neuroradiology       Date:  2019-02-02       Impact factor: 2.804

2.  Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

Authors:  Robert A Wise; Russell A Acevedo; Antonio R Anzueto; Nicola A Hanania; Fernando J Martinez; Jill A Ohar; Donald P Tashkin
Journal:  Chronic Obstr Pulm Dis       Date:  2016-11-15

3.  Abnormal intrinsic functional hubs and connectivity in stable patients with COPD: a resting-state MRI study.

Authors:  Haijun Li; Huizhen Xin; Jingjing Yu; Honghui Yu; Juan Zhang; Wenjing Wang; Dechang Peng
Journal:  Brain Imaging Behav       Date:  2020-04       Impact factor: 3.978

4.  Altered Gray Matter Volume in Stable Chronic Obstructive Pulmonary Disease with Subclinical Cognitive Impairment: an Exploratory Study.

Authors:  Chunrong Wang; Yanhui Ding; Bixian Shen; Dehong Gao; Jie An; Kewen Peng; Gangqiang Hou; Liqiu Zou; Mei Jiang; Shijun Qiu
Journal:  Neurotox Res       Date:  2016-12-22       Impact factor: 3.911

Review 5.  Chronic Obstructive Pulmonary Disease and the Risk of Stroke.

Authors:  Ann D Morgan; Chetna Sharma; Kieran J Rothnie; James Potts; Liam Smeeth; Jennifer K Quint
Journal:  Ann Am Thorac Soc       Date:  2017-05

6.  Increased pulse wave velocity is related to impaired working memory and executive function in older adults with metabolic syndrome.

Authors:  Jigar Gosalia; Polly S Montgomery; Shangming Zhang; William A Pomilla; Ming Wang; Menglu Liang; Anna Csiszar; Zoltan Ungvari; Andriy Yabluchanskiy; David N Proctor; Andrew W Gardner
Journal:  Geroscience       Date:  2022-08-18       Impact factor: 7.581

7.  Executive Function, Survival, and Hospitalization in Chronic Obstructive Pulmonary Disease. A Longitudinal Analysis of the National Emphysema Treatment Trial (NETT).

Authors:  James W Dodd; Paul Novotny; Frank C Sciurba; Roberto P Benzo
Journal:  Ann Am Thorac Soc       Date:  2015-10

Review 8.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

Review 9.  Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.

Authors:  Federico Lavorini; Claudia Mannini; Elisa Chellini; Giovanni A Fontana
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

10.  Examining the possible causal relationship between lung function, COPD and Alzheimer's disease: a Mendelian randomisation study.

Authors:  Daniel Higbee; Raquel Granell; Esther Walton; Roxanna Korologou-Linden; George Davey Smith; James Dodd
Journal:  BMJ Open Respir Res       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.